Skip to main content
SpringerLink
Log in

Intracranial Cerebrovascular Occlusive Disease

  • Chapter
  • First Online:
Book cover Handbook of Cerebrovascular Disease and Neurointerventional Technique

Part of the book series: Contemporary Medical Imaging ((CMI,volume 1))

Abstract

This chapter will discuss intracranial arterial stenosis and occlusion due to atherosclerosis and moyamoya syndrome. Approximately 8–10% of ischaemic strokes are attributable to intracranial atherosclerosis. In the USA, it is estimated that 40,000–60,000 new strokes per year are due to intracranial atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wityk RJ, Lehman D, Klag M, Coresh J, Ahn H, Litt B. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke. 1996;27:1974–80.

    Article  PubMed  CAS  Google Scholar 

  2. Sacco RL, Roberts JK, Boden-Albala B, et al. Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study. Stroke. 1997;28:929–35.

    Article  PubMed  CAS  Google Scholar 

  3. Intracranial angioplasty and stenting for cerebral atherosclerosis: a position statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology. AJNR Am J Neuroradiol. 2005; 26:2323–7.

    Google Scholar 

  4. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–16.

    Article  PubMed  CAS  Google Scholar 

  5. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17:648–55.

    Article  PubMed  CAS  Google Scholar 

  6. Gorelick PB, Caplan LR, Hier DB, et al. Racial differences in the distribution of posterior circulation occlusive disease. Stroke. 1985;16:785–90.

    Article  PubMed  CAS  Google Scholar 

  7. Bogousslavsky J, Barnett HJ, Fox AJ, Hachinski VC, Taylor W. Atherosclerotic disease of the middle cerebral artery. Stroke. 1986;17:1112–20.

    Article  PubMed  CAS  Google Scholar 

  8. Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R. Intracranial stenosis in Chinese patients with acute stroke. Neurology. 1998;50:812–3.

    Article  PubMed  CAS  Google Scholar 

  9. Hao Q, Wong LK, Lin WH, Leung TW, Kaps M, Rosengarten B. Ethnic influences on neurovascular coupling: a pilot study in whites and asians. Stroke. 2010;41:383–4.

    Article  PubMed  Google Scholar 

  10. Kremer C, Schaettin T, Georgiadis D, Baumgartner RW. Prognosis of asymptomatic stenosis of the middle cerebral artery. J Neurol Neurosurg Psychiatry. 2004;75:1300–3.

    Article  PubMed  CAS  Google Scholar 

  11. Akins PT, Pilgram TK, Cross 3rd DT, Moran CJ. Natural history of stenosis from intracranial atherosclerosis by serial angiography. Stroke. 1998;29:433–8.

    Article  PubMed  CAS  Google Scholar 

  12. Wolff V, Lauer V, Rouyer O, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke. 2011;42:1778–80.

    Article  PubMed  Google Scholar 

  13. Wilson PW. Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view. Endocrinol Metab Clin North Am. 2004;33:467–81, v.

    Article  PubMed  Google Scholar 

  14. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–9.

    Article  PubMed  Google Scholar 

  15. Naritomi H, Sawada T, Kuriyama Y, Kinugawa H, Kaneko T, Takamiya M. Effect of chronic middle cerebral artery stenosis on the local cerebral hemodynamics. Stroke. 1985;16:214–9.

    Article  PubMed  CAS  Google Scholar 

  16. Derdeyn CP, Grubb Jr RL, Powers WJ. Cerebral hemodynamic impairment: methods of measurement and association with stroke risk. Neurology. 1999;53:251.

    Article  PubMed  CAS  Google Scholar 

  17. Constantinides P. Pathogenesis of cerebral artery thrombosis in man. Arch Pathol. 1967;83:422–8.

    PubMed  CAS  Google Scholar 

  18. Craig DR, Meguro K, Watridge C, Robertson JT, Barnett HJ, Fox AJ. Intracranial internal carotid artery stenosis. Stroke. 1982;13:825–8.

    Article  PubMed  CAS  Google Scholar 

  19. Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology. 1989;39:1246–50.

    Article  PubMed  CAS  Google Scholar 

  20. Awad I, Furlan AJ, Little JR. Changes in intracranial stenotic lesions after extracranial-intracranial bypass surgery. J Neurosurg. 1984;60:771–6.

    Article  PubMed  CAS  Google Scholar 

  21. Arenillas JF, Molina CA, Montaner J, Abilleira S, Gonzalez-Sanchez MA, Alvarez-Sabin J. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke. 2001;32:2898–904.

    Article  PubMed  CAS  Google Scholar 

  22. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med. 1985; 313:1191–200.

    Google Scholar 

  23. Gao S, Wong KS, Hansberg T, Lam WW, Droste DW, Ringelstein EB. Microembolic signal predicts recurrent cerebral ischemic events in acute stroke patients with middle cerebral artery stenosis. Stroke. 2004;35:2832–6.

    Article  PubMed  Google Scholar 

  24. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66:1187–91.

    Article  PubMed  CAS  Google Scholar 

  25. Komotar RJ, Wilson DA, Mocco J, et al. Natural history of intracranial atherosclerosis: a critical review. Neurosurgery. 2006;58:595–601; discussion 595–601.

    Article  PubMed  Google Scholar 

  26. Chimowitz MI, Kokkinos J, Strong J, et al. The warfarin-aspirin symptomatic intracranial disease study. Neurology. 1995;45:1488–93.

    Article  PubMed  CAS  Google Scholar 

  27. Kasner SE, Lynn MJ, Chimowitz MI, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology. 2006;67:1275–8.

    Article  PubMed  CAS  Google Scholar 

  28. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555–63.

    Article  PubMed  Google Scholar 

  29. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143:1–13.

    Article  PubMed  CAS  Google Scholar 

  30. Amarenco P, Bogousslavsky J, Callahan 3rd A, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355:549–59.

    Article  PubMed  CAS  Google Scholar 

  31. Mori T, Mori K, Fukuoka M, Arisawa M, Honda S. Percutaneous transluminal cerebral angioplasty: serial angiographic follow-up after successful dilatation. Neuroradiology. 1997;39:111–6.

    Article  PubMed  CAS  Google Scholar 

  32. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol. 1998;19:1525–33.

    PubMed  CAS  Google Scholar 

  33. Gress DR, Smith WS, Dowd CF, Van Halbach V, Finley RJ, Higashida RT. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery. 2002;51:23–7; discussion 7–9.

    Article  PubMed  Google Scholar 

  34. Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors 3rd JJ. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol. 2006;27:1882–92.

    PubMed  CAS  Google Scholar 

  35. Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke. 2006;37:1016–20.

    Article  PubMed  Google Scholar 

  36. Yu W, Smith WS, Singh V, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis. Neurology. 2005;64:1055–7.

    Article  PubMed  CAS  Google Scholar 

  37. Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007;38:1531–7.

    Article  PubMed  CAS  Google Scholar 

  38. The SSI. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke. 2004;35:1388–92.

    Article  Google Scholar 

  39. Cruz-Flores S, Diamond A. Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev. 2006; 3:CD004133.

    Google Scholar 

  40. Mori T, Kazita K, Mori K. Cerebral angioplasty and stenting for intracranial vertebral atherosclerotic stenosis. AJNR Am J Neuroradiol. 1999;20:787–9.

    PubMed  CAS  Google Scholar 

  41. Siddiq F, Memon MZ, Vazquez G, Safdar A, Qureshi AI. Comparison between primary angioplasty and stent placement for symptomatic intracranial atherosclerotic disease: meta-analysis of case series. Neurosurgery. 2009;65:1024–34.

    Article  PubMed  Google Scholar 

  42. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003.

    Article  PubMed  CAS  Google Scholar 

  43. U.S. National Institutes of Health. VISSIT intracranial stent study for ischemic therapy. ClinicalTrials.gov. 2012 http://clinicaltrials.gov/ct2/show/NCT00816166. Accessed Feb 10, 2012.

  44. Matsushima Y. Moyamoya disease. In: Albright L, Pollack I, Adelson D, editors. Principles and practice of pediatric neurosurgery. New York: Thieme Medical Publishers, Inc.; 1999. p. 1053–69.

    Google Scholar 

  45. Rodriguez GJ, Kirmani JF, Ezzeddine MA, Qureshi AI. Primary percutaneous transluminal angioplasty for early moyamoya disease. J Neuroimaging. 2007;17:48–53.

    Article  PubMed  Google Scholar 

  46. Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg. 1997;99 Suppl 2:S1–5.

    Article  PubMed  Google Scholar 

  47. Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol. 1997;47:138–43.

    Article  PubMed  CAS  Google Scholar 

  48. Watanabe A, Omata T, Koizumi H, Nakano S, Takeuchi N, Kinouchi H. Bony carotid canal hypoplasia in patients with moyamoya disease. J Neurosurg Pediatr. 2010;5:591–4.

    Article  PubMed  Google Scholar 

  49. Ikezaki K, Han DH, Dmsci DH, Kawano T, Kinukawa N, Fukui M. A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke. 1997;28:2513–7.

    Article  PubMed  CAS  Google Scholar 

  50. Cheng MK. A review of cerebrovascular surgery in the People’s Republic of China. Stroke. 1982;13:249–55.

    Article  PubMed  CAS  Google Scholar 

  51. Matsushima Y, Qian L, Aoyagi M. Comparison of moyamoya disease in Japan and moyamoya disease (or syndrome) in the People’s Republic of China. Clin Neurol Neurosurg. 1997;99 Suppl 2:S19–22.

    Article  PubMed  Google Scholar 

  52. Uchino K, Johnston SC, Becker KJ, Tirschwell DL. Moyamoya disease in Washington State and California. Neurology. 2005;65:956–8.

    Article  PubMed  Google Scholar 

  53. Graham JF, Matoba A. A survey of moyamoya disease in Hawaii. Clin Neurol Neurosurg. 1997;99:S31–5.

    Article  PubMed  Google Scholar 

  54. Yonekawa Y, Ogata N, Kaku Y, Taub E, Imhof H-G. Moyamoya disease in Europe, past and present status. Clin Neurol Neurosurg. 1997;99:S58–60.

    Article  PubMed  Google Scholar 

  55. Nyary I. Moyamoya disease: the Hungarian experience. In: International symposium on moyamoya disease. Fukuoa; 1996.

    Google Scholar 

  56. Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular network in moyamoya disease. Stroke. 1983;14:50–8.

    Article  PubMed  CAS  Google Scholar 

  57. Hosoda Y, Ikeda E, Hirose S. Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease). Clin Neurol Neurosurg. 1997;99 Suppl 2:S203–8.

    PubMed  Google Scholar 

  58. Takagi Y, Kikuta K, Nozaki K, Hashimoto N. Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo). 2007;47:1–4.

    Article  Google Scholar 

  59. Takekawa Y, Umezawa T, Ueno Y, Sawada T, Kobayashi M. Pathological and immunohistochemical findings of an autopsy case of adult moyamoya disease. Neuropathology. 2004;24:236–42.

    Article  PubMed  Google Scholar 

  60. Li B, Wang ZC, Sun YL, Hu Y. Ultrastructural study of cerebral arteries in Moyamoya disease. Chin Med J (Engl). 1992;105:923–8.

    CAS  Google Scholar 

  61. Aoyagi M, Fukai N, Yamamoto M, Nakagawa K, Matsushima Y, Yamamoto K. Early development of intimal thickening in superficial temporal arteries in patients with moyamoya disease. Stroke. 1996;27:1750–4.

    Article  PubMed  CAS  Google Scholar 

  62. Ikeda E, Hosoda Y. Distribution of thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of Willis: cerebrovascular moyamoya disease. Clin Neuropathol. 1993;12:44–8.

    PubMed  CAS  Google Scholar 

  63. Aoyagi M, Fukai N, Sakamoto H, et al. Altered cellular responses to serum mitogens, including platelet-derived growth factor, in cultured smooth muscle cells derived from arteries of patients with moyamoya disease. J Cell Physiol. 1991;147:191–8.

    Article  PubMed  CAS  Google Scholar 

  64. Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett. 1993;160:214–6.

    Article  PubMed  CAS  Google Scholar 

  65. Malek AM, Connors S, Robertson RL, Folkman J, Scott RM. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders. Pediatr Neurosurg. 1997;27:182–9.

    Article  PubMed  CAS  Google Scholar 

  66. Hoshimaru M, Takahashi JA, Kikuchi H, Nagata I, Hatanaka M. Possible roles of basic fibroblast growth factor in the pathogenesis of moyamoya disease: an immunohistochemical study. J Neurosurg. 1991;75:267–70.

    Article  PubMed  CAS  Google Scholar 

  67. Hosoda Y, Hirose S, Kameyama K. Histopathological and immunohistochemical study of growth factor in spontaneous occlusion of the circle of Willis. In: Fukui M, editor. Annual report of the research committee on spontaneous occlusion of the circle of Willis (Moyamoya disease) 1993. Japan: Ministry of Health and Welfare; 1994. p. 25–8.

    Google Scholar 

  68. Yoshimoto T, Houkin K, Takahashi A, Abe H. Angiogenic factors in moyamoya disease. Stroke. 1996;27:2160–5.

    Article  PubMed  CAS  Google Scholar 

  69. Hojo M, Hoshimaru M, Miyamoto S, et al. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease. J Neurosurg. 1998;89:623–9.

    Article  PubMed  CAS  Google Scholar 

  70. Nanba R, Kuroda S, Ishikawa T, Houkin K, Iwasaki Y. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease. Stroke. 2004;35:2837–42.

    Article  PubMed  CAS  Google Scholar 

  71. Kang HS, Kim SK, Cho BK, Kim YY, Hwang YS, Wang KC. Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery. 2006;58:1074–80; discussion −80.

    Article  PubMed  Google Scholar 

  72. Yamamoto M, Aoyagi M, Fukai N, Matsushima Y, Yamamoto K. Increase in prostaglandin E(2) production by interleukin-1beta in arterial smooth muscle cells derived from patients with moyamoya disease. Circ Res. 1999;85:912–8.

    Article  PubMed  CAS  Google Scholar 

  73. Tanigawara T, Yamada H, Sakai N, Andoh T, Deguchi K, Iwamura M. Studies on cytomegalovirus and Epstein-Barr virus infection in moyamoya disease. Clin Neurol Neurosurg. 1997;99 Suppl 2:S225–8.

    PubMed  Google Scholar 

  74. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg. 1997;99 Suppl 2:S238–40.

    PubMed  Google Scholar 

  75. Handa J, Nakano Y, Okuno T, Komuro H, Hojyo H, Handa H. Computerized tomography in Moyamoya syndrome. Surg Neurol. 1977;7:315–9.

    PubMed  CAS  Google Scholar 

  76. Robertson RL, Chavali RV, Robson CD, et al. Neurologic complications of cerebral angiography in childhood moyamoya syndrome. Pediatr Radiol. 1998;28:824–9.

    Article  PubMed  CAS  Google Scholar 

  77. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y. Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke. 2007;38:1430–5.

    Article  PubMed  Google Scholar 

  78. Yamada I, Himeno Y, Suzuki S, Matsushima Y. Posterior circulation in moyamoya disease: angiographic study. Radiology. 1995;197:239–46.

    PubMed  CAS  Google Scholar 

  79. Komiyama M, Nishikawa M, Yasui T, Kitano S, Sakamoto H, Fu Y. Steno-occlusive changes in the external carotid system in moyamoya disease. Acta Neurochir (Wien). 2000;142:421–4.

    Article  CAS  Google Scholar 

  80. Hoshimaru M, Kikuchi H. Involvement of the external carotid arteries in moyamoya disease: neuroradiological evaluation of 66 patients. Neurosurgery. 1992;31:398–400.

    Article  PubMed  CAS  Google Scholar 

  81. Suzuki J, Kodama N. Cerebrovascular “Moyamoya” disease. 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology. 1971;22:223–36.

    Article  PubMed  CAS  Google Scholar 

  82. Kodama N, Fujiwara S, Horie Y, Kayama T, Suzuki J. Transdural anastomosis in moyamoya disease – vault moyamoy (author’s transl). No Shinkei Geka. 1980;8:729–37.

    PubMed  CAS  Google Scholar 

  83. Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Ikota T, Takeuchi S. Study of the posterior circulation in moyamoya disease. Clinical and neuroradiological evaluation. J Neurosurg. 1984;61:1032–7.

    Article  PubMed  CAS  Google Scholar 

  84. Piao R, Oku N, Kitagawa K, et al. Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation. Ann Nucl Med. 2004;18:115–21.

    Article  PubMed  Google Scholar 

  85. Wang MY, Steinberg GK. Rapid and near-complete resolution of moyamoya vessels in a patient with moyamoya disease treated with superficial temporal artery-middle cerebral artery bypass. Pediatr Neurosurg. 1996;24:145–50.

    Article  PubMed  CAS  Google Scholar 

  86. Yabumoto M, Funahashi K, Fujii T, Hayashi S, Komai N. Moyamoya disease associated with intracranial aneurysms. Surg Neurol. 1983;20:20–4.

    Article  PubMed  CAS  Google Scholar 

  87. Borota L, Marinkovic S, Bajic R, Kovacevic M. Intracranial aneurysms associated with moyamoya disease. Neurol Med Chir (Tokyo). 1996;36:860–4.

    Article  CAS  Google Scholar 

  88. Yonekawa Y, Kahn N. Moyamoya disease. Adv Neurol. 2003;92:113–8.

    PubMed  Google Scholar 

  89. Chiu D, Shedden P, Bratina P, Grotta JC. Clinical features of moyamoya disease in the United States. Stroke. 1998;29:1347–51.

    Article  PubMed  CAS  Google Scholar 

  90. Yonekawa Y, Taub E. Moyamoya disease: status. Neurologist. 1998;1999:13–23.

    Google Scholar 

  91. Komiyama M, Nakajima H, Nishikawa M, et al. High incidence of persistent primitive arteries in moyamoya and quasi-moyamoya diseases. Neurol Med Chir (Tokyo). 1999;39:416–20; discussion 20–2.

    Article  CAS  Google Scholar 

  92. Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology. 1995;196:211–8.

    PubMed  CAS  Google Scholar 

  93. Yamada I, Suzuki S, Matsushima Y. Moyamoya disease: diagnostic accuracy of MRI. Neuroradiology. 1995;37:356–61.

    Article  PubMed  CAS  Google Scholar 

  94. Hasuo K, Mihara F, Matsushima T. MRI and MR angiography in moyamoya disease. J Magn Reson Imaging. 1998;8:762–6.

    Article  PubMed  CAS  Google Scholar 

  95. Yoon H-K, Shin H-J, Chang YW. “Ivy sign” in childhood moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images. Radiology. 2002;223:384–9.

    Article  PubMed  Google Scholar 

  96. Ohta T, Tanaka H, Kuroiwa T. Diffuse leptomeningeal enhancement, “ivy sign,” in magnetic resonance images of moyamoya disease in childhood: case report. Neurosurgery. 1995;37:1009–12.

    Article  PubMed  CAS  Google Scholar 

  97. Maeda M, Tsuchida C. “Ivy sign” on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR Am J Neuroradiol. 1999;20:1836–8.

    PubMed  CAS  Google Scholar 

  98. Iwama T, Akiyama Y, Morimoto M, Kojima A, Hayashida K. Comparison of positron emission tomography study results of cerebral hemodynamics in patients with bleeding- and ischemic-type moyamoya disease. Neurosurg Focus. 1998;5:e3.

    Article  PubMed  CAS  Google Scholar 

  99. McAuley DJ, Poskitt K, Steinbok P. Predicting stroke risk in pediatric moyamoya disease with xenon-enhanced computed tomography. Neurosurgery. 2004;55:327–32; discussion 32–3.

    Article  PubMed  Google Scholar 

  100. El Ramahi KM, Al Rayes HM. Systemic lupus erythematosus associated with moyamoya syndrome. Lupus. 2000;9:632–6.

    Article  PubMed  Google Scholar 

  101. Ogawa A, Nakamura N, Yoshimoto T, Suzuki J. Cerebral blood flow in moyamoya disease. Part 2: autoregulation and CO2 response. Acta Neurochir (Wien). 1990;105:107–11.

    Article  CAS  Google Scholar 

  102. Ogawa A, Yoshimoto T, Suzuki J, Sakurai Y. Cerebral blood flow in moyamoya disease. Part 1: correlation with age and regional distribution. Acta Neurochir (Wien). 1990;105:30–4.

    Article  CAS  Google Scholar 

  103. Kohno K, Oka Y, Kohno S, Ohta S, Kumon Y, Sakaki S. Cerebral blood flow measurement as an indicator for an indirect revascularization procedure for adult patients with moyamoya disease. Neurosurgery. 1998;42:752–7; discussion 7–8.

    Article  PubMed  CAS  Google Scholar 

  104. Han DH, Nam DH, Oh CW. Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephalo-duro-arterio-synangiosis. Clin Neurol Neurosurg. 1997;99 Suppl 2:S151–5.

    PubMed  Google Scholar 

  105. Honda M, Ezaki Y, Kitagawa N, Tsutsumi K, Ogawa Y, Nagata I. Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography. Surg Neurol. 2006;66:155–9; discussion 9.

    Article  PubMed  Google Scholar 

  106. Nariai T, Matsushima Y, Imae S, et al. Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study. J Neurol Neurosurg Psychiatry. 2005;76:663–9.

    Article  PubMed  CAS  Google Scholar 

  107. Nariai T, Suzuki R, Matsushima Y, et al. Surgically induced angiogenesis to compensate for hemodynamic cerebral ischemia. Stroke. 1994;25:1014–21.

    Article  PubMed  CAS  Google Scholar 

  108. Kodama N, Aoki Y, Hiraga H, Wada T, Suzuki J. Electroencephalographic findings in children with moyamoya disease. Arch Neurol. 1979;36:16–9.

    Article  PubMed  CAS  Google Scholar 

  109. Qiao F, Kuroda S, Kamada K, Houkin K, Iwasaki Y. Source localization of the re-build up phenomenon in pediatric moyamoya disease-a dipole distribution analysis using MEG and SPECT. Childs Nerv Syst. 2003;19:760–4.

    Article  PubMed  Google Scholar 

  110. Kuroda S, Kamiyama H, Isobe M, Houkin K, Abe H, Mitsumori K. Cerebral hemodynamics and “re-build-up” phenomenon on electroencephalogram in children with moyamoya disease. Childs Nerv Syst. 1995;11:214–9.

    Article  PubMed  CAS  Google Scholar 

  111. Matsushima Y, Aoyagi M, Niimi Y, Masaoka H, Ohno K. Symptoms and their pattern of progression in childhood moyamoya disease. Brain Dev. 1990;12:784–9.

    Article  PubMed  CAS  Google Scholar 

  112. Moritake K, Handa H, Yonekawa Y, Taki W, Okuno T. Follow-up study on the relationship between age at onset of illness and outcome in patients with moyamoya disease. No Shinkei Geka. 1986;14:957–63.

    PubMed  CAS  Google Scholar 

  113. Iwama T, Morimoto M, Hashimoto N, Goto Y, Todaka T, Sawada M. Mechanism of intracranial rebleeding in moyamoya disease. Clin Neurol Neurosurg. 1997;99 Suppl 2:S187–90.

    Article  PubMed  Google Scholar 

  114. Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A. Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg. 2000;93:976–80.

    Article  PubMed  CAS  Google Scholar 

  115. Seol HJ, Wang KC, Kim SK, et al. Unilateral (probable) moyamoya disease: long-term follow-up of seven cases. Childs Nerv Syst. 2006;22:145–50.

    Article  PubMed  Google Scholar 

  116. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK. Progression of unilateral moyamoya disease: a clinical series. Cerebrovasc Dis. 2006;22:109–15.

    Article  PubMed  Google Scholar 

  117. Ikezaki K, Inamura T, Kawano T, Fukui M. Clinical features of probable moyamoya disease in Japan. Clin Neurol Neurosurg. 1997;99 Suppl 2:S173–7.

    PubMed  Google Scholar 

  118. Houkin K, Abe H, Yoshimoto T, Takahashi A. Is “unilateral” moyamoya disease different from moyamoya disease? J Neurosurg. 1996;85:772–6.

    Article  PubMed  CAS  Google Scholar 

  119. Kusaka N, Tamiya T, Adachi Y, et al. Adult unilateral moyamoya disease with familial occurrence in two definite cases: a case report and review of the literature. Neurosurg Rev. 2006;29:82–7.

    Article  PubMed  Google Scholar 

  120. Nanba R, Kuroda S, Tada M, Ishikawa T, Houkin K, Iwasaki Y. Clinical features of familial moyamoya disease. Childs Nerv Syst. 2006;22:258–62.

    Article  PubMed  Google Scholar 

  121. Kanai N. A genetic study of spontaneous occlusion of the circle of Willis (moyamoya disease). J Tokyo Women Med Univ. 1992;62:1227–58.

    Google Scholar 

  122. Kitahara T, Ariga N, Yamaura A, Makino H, Maki Y. Familial occurrence of moya-moya disease: report of three Japanese families. J Neurol Neurosurg Psychiatry. 1979;42:208–14.

    Article  PubMed  CAS  Google Scholar 

  123. Yamada H, Nakamura S, Kageyama N. Moyamoya disease in monovular twins: case report. J Neurosurg. 1980;53:109–12.

    Article  PubMed  CAS  Google Scholar 

  124. Yamauchi T, Houkin K, Tada M, Abe H. Familial occurrence of moyamoya disease. Clin Neurol Neurosurg. 1997;99 Suppl 2:S162–7.

    PubMed  Google Scholar 

  125. Mineharu Y, Takenaka K, Yamakawa H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006;77:1025–9.

    Article  PubMed  CAS  Google Scholar 

  126. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533–7.

    Article  PubMed  CAS  Google Scholar 

  127. Yamauchi T, Tada M, Houkin K, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930–5.

    Article  PubMed  CAS  Google Scholar 

  128. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000;15:179–82.

    Article  PubMed  CAS  Google Scholar 

  129. Sakurai K, Horiuchi Y, Ikeda H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004;49:278–81.

    Article  PubMed  CAS  Google Scholar 

  130. Lee CM, Lee SY, Ryu SH, Lee SW, Park KW, Chung WT. Systemic lupus erythematosus associated with familial moyamoya disease. Korean J Intern Med. 2003;18:244–7.

    PubMed  Google Scholar 

  131. Akutsu H, Sonobe M, Sugita K, Nakai Y, Matsumura A. Familial association of basilar bifurcation aneurysm and moyamoya disease – four case reports. Neurol Med Chir (Tokyo). 2003;43:435–8.

    Article  Google Scholar 

  132. Houkin K, Tanaka N, Takahashi A, Kamiyama H, Abe H, Kajii N. Familial occurrence of moyamoya disease. Magnetic resonance angiography as a screening test for high-risk subjects. Childs Nerv Syst. 1994;10:421–5.

    Article  PubMed  CAS  Google Scholar 

  133. Im SH, Oh CW, Kwon OK, Kim JE, Han DH. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. J Neurosurg. 2005;102:1013–7.

    Article  PubMed  Google Scholar 

  134. Sasaki T, Nogawa S, Amano T. Co-morbidity of moyamoya disease with Graves’ disease. Report of three cases and a review of the literature. Intern Med. 2006;45:649–53.

    Article  PubMed  Google Scholar 

  135. Nagahiro S, Mantani A, Yamada K, Ushio Y. Multiple cerebral arterial occlusions in a young patient with Sjogren’s syndrome: case report. Neurosurgery. 1996;38:592–5; discussion 5.

    PubMed  CAS  Google Scholar 

  136. Matsuki Y, Kawakami M, Ishizuka T, et al. SLE and Sjogren’s syndrome associated with unilateral moyamoya vessels in cerebral arteries. Scand J Rheumatol. 1997;26:392–4.

    Article  PubMed  CAS  Google Scholar 

  137. Booth F, Yanofsky R, Ross IB, Lawrence P, Oen K. Primary antiphospholipid syndrome with moyamoya-like vascular changes. Pediatr Neurosurg. 1999;31:45–8.

    Article  PubMed  CAS  Google Scholar 

  138. Shuja-Ud-Din MA, Ahamed SA, Baidas G, Naeem M. Moyamoya syndrome with primary antiphospholipid syndrome. Med Princ Pract. 2006;15:238–41.

    Article  PubMed  Google Scholar 

  139. Czartoski T, Hallam D, Lacy JM, Chun MR, Becker K. Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry. 2005;76:256–9.

    Article  PubMed  CAS  Google Scholar 

  140. Mathew NT, Abraham J, Chandy J. Cerebral angiographic features in tuberculous meningitis. Neurology. 1970;20:1015–23.

    Article  PubMed  CAS  Google Scholar 

  141. Nakayama Y, Tanaka A, Nagasaka S, Ikui H. Intracerebral hemorrhage in a patient with moyamoya phenomenon caused by tuberculous arteritis: a case report. No Shinkei Geka. 1999;27:751–5.

    PubMed  CAS  Google Scholar 

  142. Hsiung GY, Sotero de Menezes M. Moyamoya syndrome in a patient with congenital human immunodeficiency virus infection. J Child Neurol. 1999;14:268–70.

    Article  PubMed  CAS  Google Scholar 

  143. Dobson SR, Holden KR, Nietert PJ, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood. 2002;99:3144–50.

    Article  PubMed  CAS  Google Scholar 

  144. Tomura N, Inugami A, Higano S, et al. Cases similar to cerebrovascular moyamoya disease – investigation by angiography and computed tomography. No To Shinkei. 1988;40:905–12.

    PubMed  CAS  Google Scholar 

  145. Cohen N, Berant M, Simon J. Moyamoya and Fanconi’s anemia. Pediatrics. 1980;65:804–5.

    PubMed  CAS  Google Scholar 

  146. Pavlakis SG, Verlander PC, Gould RJ, Strimling BC, Auerbach AD. Fanconi anemia and moyamoya: evidence for an association. Neurology. 1995;45:998–1000.

    Article  PubMed  CAS  Google Scholar 

  147. Tokunaga Y, Ohga S, Suita S, Matsushima T, Hara T. Moyamoya syndrome with spherocytosis: effect of splenectomy on strokes. Pediatr Neurol. 2001;25:75–7.

    Article  PubMed  CAS  Google Scholar 

  148. Sanefuji M, Ohga S, Kira R, Yoshiura T, Torisu H, Hara T. Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia. J Child Neurol. 2006;21:75–7.

    Article  PubMed  Google Scholar 

  149. Matsuda M, Enomoto T, Yanaka K, Nose T. Moyamoya disease associated with hemophilia A. Case report. Pediatr Neurosurg. 2002;36:157–60.

    Article  PubMed  Google Scholar 

  150. Hiyama H, Kusano R, Muragaki Y, Miura N. Moyamoya disease associated with thrombotic thrombocytopenic purpura (TTP). No Shinkei Geka. 1994;22:567–72.

    PubMed  CAS  Google Scholar 

  151. Brockmann K, Stolpe S, Fels C, Khan N, Kulozik AE, Pekrun A. Moyamoya syndrome associated with hemolytic anemia due to Hb Alesha. J Pediatr Hematol Oncol. 2005;27:436–40.

    Article  PubMed  Google Scholar 

  152. Kornblihtt LI, Cocorullo S, Miranda C, Lylyk P, Heller PG, Molinas FC. Moyamoya syndrome in an adolescent with essential thrombocythemia: successful intracranial carotid stent placement. Stroke. 2005;36:E71–3.

    Article  PubMed  Google Scholar 

  153. Kikuchi A, Maeda M, Hanada R, et al. Moyamoya syndrome following childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2007;48:268–72.

    Article  PubMed  Google Scholar 

  154. Andeejani AM, Salih MA, Kolawole T, et al. Moyamoya syndrome with unusual angiographic findings and protein C deficiency: review of the literature. J Neurol Sci. 1998;159:11–6.

    Article  PubMed  CAS  Google Scholar 

  155. Akgun D, YiLmaz S, Senbil N, Aslan B, Gurer YY. Moyamoya syndrome with protein S deficiency. Eur J Paediatr Neurol. 2000;4:185–8.

    Article  PubMed  CAS  Google Scholar 

  156. Kikuta K, Miyamoto S, Kataoka H, et al. An adult case of moyamoya syndrome that developed dural sinus thrombosis associated with protein C deficiency: case report and literature review. Surg Neurol. 2005;63:480–4; discussion 4.

    Article  PubMed  Google Scholar 

  157. Cheong PL, Lee WT, Liu HM, Lin KH. Moyamoya syndrome with inherited proteins C and S deficiency: report of one case. Acta Paediatr Taiwan. 2005;46:31–4.

    PubMed  Google Scholar 

  158. Dhopesh VP, Dunn DP, Schick P. Moyamoya and Hageman factor (Factor XII) deficiency in a black adult. Arch Neurol. 1978;35:396.

    Article  PubMed  CAS  Google Scholar 

  159. Likavcan M, Benko J, Papiernikova E, Lindtnerova L. Moyamoya syndrome with hyperlipoproteinemia type IIa. Cesk Neurol Neurochir. 1979;42:49–53.

    PubMed  CAS  Google Scholar 

  160. Goutieres F, Bourgeois M, Trioche P, Demelier JF, Odievre M, Labrune P. Moyamoya disease in a child with glycogen storage disease type Ia. Neuropediatrics. 1997;28:133–4.

    Article  PubMed  CAS  Google Scholar 

  161. Meyer S, Zanardo L, Kaminski WE, et al. Elastosis perforans serpiginosa-like pseudoxanthoma elasticum in a child with severe Moya Moya disease. Br J Dermatol. 2005;153:431–4.

    Article  PubMed  CAS  Google Scholar 

  162. Squizzato A, Gerdes VE, Brandjes DP, Buller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke. 2005;36:2302–10.

    Article  PubMed  CAS  Google Scholar 

  163. Cerrato P, Grasso M, Lentini A, et al. Atherosclerotic adult Moya-Moya disease in a patient with hyperhomocysteinaemia. Neurol Sci. 2007;28:45–7.

    Article  PubMed  CAS  Google Scholar 

  164. Cramer SC, Robertson RL, Dooling EC, Scott RM. Moyamoya and Down syndrome. Clinical and radiological features. Stroke. 1996;27:2131–5.

    Article  PubMed  CAS  Google Scholar 

  165. Kwong KL, Wong YC. Moyamoya disease in a child with neurofibromatosis type-1. J Paediatr Child Health. 1999;35:108–9.

    PubMed  CAS  Google Scholar 

  166. Inoue T, Matsushima T, Fujii K, Fukui M, Hasuo K, Matsuo H. Akin moyamoya disease in children. No Shinkei Geka. 1993;21:59–65.

    PubMed  CAS  Google Scholar 

  167. Spengos K, Kosmaidou-Aravidou Z, Tsivgoulis G, Vassilopoulou S, Grigori-Kostaraki P, Zis V. Moyamoya syndrome in a Caucasian woman with Turner’s syndrome. Eur J Neurol. 2006;13:e7–8.

    Article  PubMed  CAS  Google Scholar 

  168. Kawai M, Nishikawa T, Tanaka M, et al. An autopsied case of Williams syndrome complicated by moyamoya disease. Acta Paediatr Jpn. 1993;35:63–7.

    Article  PubMed  CAS  Google Scholar 

  169. Imaizumi M, Nukada T, Yoneda S, Takano T, Hasegawa K, Abe H. Tuberous sclerosis with moyamoya disease. Case report. Med J Osaka Univ. 1978;28:345–53.

    PubMed  CAS  Google Scholar 

  170. Albayram S, Kizilkilic O, Yilmaz H, Tuysuz B, Kocer N, Islak C. Abnormalities in the cerebral arterial system in osteogenesis imperfecta. AJNR Am J Neuroradiol. 2003;24:748–50.

    PubMed  Google Scholar 

  171. Ganesan V, Kirkham FJ. Noonan syndrome and moyamoya. Pediatr Neurol. 1997;16:256–8.

    Article  PubMed  CAS  Google Scholar 

  172. Yamashita Y, Kusaga A, Koga Y, Nagamitsu S, Matsuishi T. Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndrome. Pediatr Neurol. 2004;31:364–6.

    Article  PubMed  Google Scholar 

  173. Shiihara T, Kato M, Mitsuhashi Y, Hayasaka K. Costello syndrome showing moyamoya-like vasculopathy. Pediatr Neurol. 2005;32:361–3.

    Article  PubMed  Google Scholar 

  174. Rachmel A, Zeharia A, Neuman-Levin M, Weitz R, Shamir R, Dinari G. Alagille syndrome associated with moyamoya disease. Am J Med Genet. 1989;33:89–91.

    Article  PubMed  CAS  Google Scholar 

  175. Emerick KM, Krantz ID, Kamath BM, et al. Intracranial vascular abnormalities in patients with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2005;41:99–107.

    Article  PubMed  Google Scholar 

  176. Girirajan S, Mendoza-Londono R, Vlangos CN, et al. Smith-Magenis syndrome and moyamoya disease in a patient with del(17)(p11.2p13.1). Am J Med Genet A. 2007;143:999–1008.

    Google Scholar 

  177. Kim YO, Baek HJ, Woo YJ, Choi YY, Chung TW. Moyamoya syndrome in a child with trisomy 12p syndrome. Pediatr Neurol. 2006;35:442–5.

    Article  PubMed  Google Scholar 

  178. Pilz P, Hartjes HJ. Fibromuscular dysplasia and multiple dissecting aneurysms of intracranial arteries. A further cause of Moyamoya syndrome. Stroke. 1976;7:393–8.

    Article  PubMed  CAS  Google Scholar 

  179. Pracyk JB, Massey JM. Moyamoya disease associated with polycystic kidney disease and eosinophilic granuloma. Stroke. 1989;20:1092–4.

    Article  PubMed  CAS  Google Scholar 

  180. Terada T, Yokote H, Tsuura M, Nakai K, Ohshima A, Itakura T. Marfan syndrome associated with moyamoya phenomenon and aortic dissection. Acta Neurochir (Wien). 1999;141:663–5.

    Article  CAS  Google Scholar 

  181. Terajima K, Shimohata T, Watanabe M, et al. Cerebral vasculopathy showing moyamoya-like changes in a patient with CREST syndrome. Eur Neurol. 2001;46:163–5.

    Article  PubMed  CAS  Google Scholar 

  182. Lau YL, Milligan DW. Atypical presentation of craniopharyngioma associated with moyamoya disease. J R Soc Med. 1986;79:236–7.

    PubMed  CAS  Google Scholar 

  183. Arita K, Uozumi T, Oki S, et al. Moyamoya disease associated with pituitary adenoma – report of two cases. Neurol Med Chir (Tokyo). 1992;32:753–7.

    Article  CAS  Google Scholar 

  184. Kitano S, Sakamoto H, Fujitani K, Kobayashi Y. Moyamoya disease associated with a brain stem glioma. Childs Nerv Syst. 2000;16:251–5.

    Article  PubMed  CAS  Google Scholar 

  185. Watanabe Y, Todani T, Fujii T, Toki A, Uemura S, Koike Y. Wilms’ tumor associated with Moyamoya disease: a case report. Z Kinderchir. 1985;40:114–6.

    PubMed  CAS  Google Scholar 

  186. Sequeira W, Naseem M, Bouffard DA. An association with birth control pills. Moyamoya. IMJ Ill Med J. 1984;166:434–6.

    PubMed  CAS  Google Scholar 

  187. Schwartz MS, Scott RM. Moyamoya syndrome associated with cocaine abuse. Case report. Neurosurg Focus. 1998;5:e7.

    PubMed  CAS  Google Scholar 

  188. Storen EC, Wijdicks EF, Crum BA, Schultz G. Moyamoya-like vasculopathy from cocaine dependency. AJNR Am J Neuroradiol. 2000;21:1008–10.

    PubMed  CAS  Google Scholar 

  189. Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke. 1995;26:131–6.

    Article  PubMed  CAS  Google Scholar 

  190. Desai SS, Paulino AC, Mai WY, Teh BS. Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys. 2006;65:1222–7.

    Article  PubMed  Google Scholar 

  191. Ullrich NJ, Robertson R, Kinnamon DD, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007;68:932–8.

    Article  PubMed  CAS  Google Scholar 

  192. Steinke W, Tatemichi TK, Mohr JP, Massaro A, Prohovnik I, Solomon RA. Caudate hemorrhage with moyamoya-like vasculopathy from atherosclerotic disease. Stroke. 1992;23:1360–3.

    Article  PubMed  CAS  Google Scholar 

  193. Joo SP, Kim TS, Lee JH, et al. Moyamoya disease associated with Behcet’s disease. J Clin Neurosci. 2006;13:364–7.

    Article  PubMed  Google Scholar 

  194. Taskintuna I, Oz O, Teke MY, Kocak H, Firat E. Morning glory syndrome: association with moyamoya disease, midline cranial defects, central nervous system anomalies, and persistent hyaloid artery remnant. Retina. 2003;23:400–2.

    Article  PubMed  Google Scholar 

  195. Mawad ME, Hilal SK, Michelsen WJ, Stein B, Ganti SR. Occlusive vascular disease associated with cerebral arteriovenous malformations. Radiology. 1984;153:401–8.

    PubMed  CAS  Google Scholar 

  196. Nakashima T, Nakayama N, Furuichi M, Kokuzawa J, Murakawa T, Sakai N. Arteriovenous malformation in association with moyamoya disease. Report of two cases. Neurosurg Focus. 1998;5:e6.

    Article  PubMed  CAS  Google Scholar 

  197. Yamada K, Hayakawa T, Ushio Y, Mitomo M. Cerebral arterial dolichoectasia associated with moyamoya vessels. Surg Neurol. 1985;23:19–24.

    Article  PubMed  CAS  Google Scholar 

  198. Katayama W, Enomoto T, Yanaka K, Nose T. Moyamoya disease associated with persistent primitive hypoglossal artery: report of a case. Pediatr Neurosurg. 2001;35:262–5.

    Article  PubMed  CAS  Google Scholar 

  199. Shoskes DA, Novick AC. Surgical treatment of renovascular hypertension in moyamoya disease: case report and review of the literature. J Urol. 1995;153:450–2.

    Article  PubMed  CAS  Google Scholar 

  200. Bayrakci B, Topaloglu R, Cila A, Saatci I. Renovascular hypertension and prolonged encephalopathy associated with moyamoya disease. Eur J Pediatr. 1999;158:342.

    Article  PubMed  CAS  Google Scholar 

  201. Tsuruta D, Fukai K, Seto M, et al. Phakomatosis pigmentovascularis type IIIb associated with moyamoya disease. Pediatr Dermatol. 1999;16:35–8.

    Article  PubMed  CAS  Google Scholar 

  202. Takenaka K, Ito M, Kumagai M, et al. Moyamoya disease associated with pulmonary sarcoidosis – case report. Neurol Med Chir (Tokyo). 1998;38:566–8.

    Article  CAS  Google Scholar 

  203. Sharma J, Sehgal KV, Harmon RL. Heterotopic ossification in moyamoya disease: a case report. Am J Phys Med Rehabil. 1998;77:455–7.

    Article  PubMed  CAS  Google Scholar 

  204. Lutterman J, Scott M, Nass R, Geva T. Moyamoya syndrome associated with congenital heart disease. Pediatrics. 1998;101:57–60.

    Article  PubMed  CAS  Google Scholar 

  205. Fernandez-Alvarez E, Pineda M, Royo C, Manzanares R. ‘Moya-moya’ disease caused by cranial trauma. Brain Dev. 1979;1:133–8.

    Article  PubMed  CAS  Google Scholar 

  206. Fukui M, Natori Y, Matsushima T, Ikezaki K. Surgical treatment of diseases akin to Moyamoya disease in children. In: Fukui M, ed. Annual report of the 1995 research committee on spontaneous occlusion of the circle of Willis. Tokyo, Japan; 1996.

    Google Scholar 

  207. Goldenberg HJ. ‘Moyamoya’ associated with peripheral vascular occlusive disease. Arch Dis Child. 1974;49:964–6.

    Article  PubMed  CAS  Google Scholar 

  208. Peerless SJ. Risk factors of moyamoya disease in Canada and the USA. Clin Neurol Neurosurg. 1997;99 Suppl 2:S45–8.

    Article  PubMed  Google Scholar 

  209. Hallemeier CL, Rich KM, Grubb Jr RL, et al. Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke. 2006;37:1490–6.

    Article  PubMed  Google Scholar 

  210. Suzuki J, Takaku A, Kodama N, Sato S. An attempt to treat cerebrovascular ‘Moyamoya’ disease in children. Childs Brain. 1975;1:193–206.

    PubMed  CAS  Google Scholar 

  211. Donaghy RM. Neurologic surgery. Surg Gynecol Obstet. 1972;134:269–70.

    PubMed  CAS  Google Scholar 

  212. Spetzler R, Chater N. Occipital artery – middle cerebral artery anastomosis for cerebral artery occlusive disease. Surg Neurol. 1974;2:235–8.

    PubMed  CAS  Google Scholar 

  213. Ikeda A, Yamamoto I, Sato O, Morota N, Tsuji T, Seguchi T. Revascularization of the calcarine artery in moyamoya disease: OA-cortical PCA anastomosis – case report. Neurol Med Chir (Tokyo). 1991;31:658–61.

    Article  CAS  Google Scholar 

  214. Ishii R, Koike T, Takeuchi S, Ohsugi S, Tanaka R, Konno K. Anastomosis of the superficial temporal artery to the distal anterior cerebral artery with interposed cephalic vein graft. Case report. J Neurosurg. 1983;58:425–9.

    Article  PubMed  CAS  Google Scholar 

  215. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst. 2005;21:358–64.

    Article  PubMed  Google Scholar 

  216. Mizoi K, Kayama T, Yoshimoto T, Nagamine Y. Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients? Surg Neurol. 1996;45:541–8; discussion 8–9.

    Article  PubMed  CAS  Google Scholar 

  217. Choi JU, Seok Kim D, Kim EY, Lee KC. Natural history of Moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg. 1997;99:S11–8.

    Article  PubMed  Google Scholar 

  218. Sittig O. Klinische Beitrage zur Lehre von der Lokalisation der sensiblen Rindenzentren. Prag Med Wohenschr. 1914;45:548–50.

    Google Scholar 

  219. Sasamori T, Kuroda S, Nakayama N, Iwasaki Y. Incidence and pathogenesis of transient cheiro-oral syndrome after surgical revascularization for moyamoya disease. Neurosurgery. 2010;67:1054–60.

    Article  PubMed  Google Scholar 

  220. Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y. Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: an extensive follow-up study. Stroke. 1999;30:2272–6.

    Article  PubMed  CAS  Google Scholar 

  221. Kuroda S, Houkin K, Kamiyama H, Abe H. Effects of surgical revascularization on peripheral artery aneurysms in moyamoya disease: report of three cases. Neurosurgery. 2001;49:463–7; discussion 7–8.

    PubMed  CAS  Google Scholar 

  222. Drazin D, Calayag M, Gifford E, Dalfino J, Yamamoto J, Boulos AS. Endovascular treatment for moyamoya disease in a Caucasian twin with angioplasty and Wingspan stent. Clin Neurol Neurosurg. 2009;111:913–7.

    Article  PubMed  Google Scholar 

  223. El-Hakam LM, Volpi J, Mawad M, Clark G. Angioplasty for acute stroke with pediatric moyamoya syndrome. J Child Neurol. 2010;25:1278–83.

    Article  PubMed  Google Scholar 

  224. Khan N, Dodd R, Marks MP, Bell-Stephens T, Vavao J, Steinberg GK. Failure of primary percutaneous angioplasty and stenting in the prevention of ischemia in Moyamoya angiopathy. Cerebrovasc Dis. 2011;31:147–53.

    Article  PubMed  Google Scholar 

  225. Komiyama M, Yasui T, Kitano S, Sakamoto H, Fujitani K, Matsuo S. Moyamoya disease and pregnancy: case report and review of the literature. Neurosurgery. 1998;43:360–8; discussion 8–9.

    Article  PubMed  CAS  Google Scholar 

  226. Kato K, Tomura N, Takahashi S, et al. A case of moyamoya-like vessels combined with brain anomaly. Radiat Med. 1999;17:373–7.

    PubMed  CAS  Google Scholar 

  227. Khan N, Schinzel A, Shuknecht B, Baumann F, Ostergaard JR, Yonekawa Y. Moyamoya angiopathy with dolichoectatic internal carotid arteries, patent ductus arteriosus and pupillary dysfunction: a new genetic syndrome? Eur Neurol. 2004;51:72–7.

    Article  PubMed  Google Scholar 

  228. Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21:643–6.

    PubMed  CAS  Google Scholar 

  229. Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288–99.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Division of Neurosurgery, and Departments of Radiology and Neurology, University of Alabama, Birmingham, AL, USA

    Mark R. Harrigan M.D.

  2. Bayfront Medical Center, St. Petersburg, FL, USA

    John P. Deveikis M.D.

Authors
  1. Mark R. Harrigan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John P. Deveikis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Harrigan, M.R., Deveikis, J.P. (2013). Intracranial Cerebrovascular Occlusive Disease. In: Handbook of Cerebrovascular Disease and Neurointerventional Technique. Contemporary Medical Imaging, vol 1. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-946-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-946-4_19

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-945-7

  • Online ISBN: 978-1-61779-946-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation